These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 18241275

  • 1. Antitumour effects in mycosis fungoides of the immunomodulatory, tellurium-based compound, AS101.
    Frei GM, Kremer M, Hanschmann KM, Krause S, Albeck M, Sredni B, Schnierle BS.
    Br J Dermatol; 2008 Mar; 158(3):578-86. PubMed ID: 18241275
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The effect of the novel tellurium compound AS101 on autoimmune diseases.
    Halpert G, Sredni B.
    Autoimmun Rev; 2014 Dec; 13(12):1230-5. PubMed ID: 25153485
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The organotellurium compound ammonium trichloro(dioxoethylene-o,o')tellurate reacts with homocysteine to form homocystine and decreases homocysteine levels in hyperhomocysteinemic mice.
    Okun E, Dikshtein Y, Carmely A, Saida H, Frei G, Sela BA, Varshavsky L, Ofir A, Levy E, Albeck M, Sredni B.
    FEBS J; 2007 Jun; 274(12):3159-70. PubMed ID: 17521335
    [Abstract] [Full Text] [Related]

  • 6. The antitumoral effect of the immunomodulator AS101 and paclitaxel (Taxol) in a murine model of lung adenocarcinoma.
    Kalechman Y, Shani A, Dovrat S, Whisnant JK, Mettinger K, Albeck M, Sredni B.
    J Immunol; 1996 Feb 01; 156(3):1101-9. PubMed ID: 8557985
    [Abstract] [Full Text] [Related]

  • 7. Predominance of TH1 response in tumor-bearing mice and cancer patients treated with AS101.
    Sredni B, Tichler T, Shani A, Catane R, Kaufman B, Strassmann G, Albeck M, Kalechman Y.
    J Natl Cancer Inst; 1996 Sep 18; 88(18):1276-84. PubMed ID: 8797767
    [Abstract] [Full Text] [Related]

  • 8. The immunomodulatory tellurium compound ammonium trichloro (dioxoethylene-O,O') tellurate reduces anxiety-like behavior and corticosterone levels of submissive mice.
    Gross M, Stanciu E, Kenigsbuch-Sredni D, Sredni B, Pinhasov A.
    Behav Pharmacol; 2017 Sep 18; 28(6):458-465. PubMed ID: 28590303
    [Abstract] [Full Text] [Related]

  • 9. The immunomodulator AS101 induces growth arrest and apoptosis in multiple myeloma: association with the Akt/survivin pathway.
    Hayun M, Naor Y, Weil M, Albeck M, Peled A, Don J, Haran-Ghera N, Sredni B.
    Biochem Pharmacol; 2006 Nov 30; 72(11):1423-31. PubMed ID: 16889755
    [Abstract] [Full Text] [Related]

  • 10. Hair growth induction by the Tellurium immunomodulator AS101: association with delayed terminal differentiation of follicular keratinocytes and ras-dependent up-regulation of KGF expression.
    Sredni B, Gal R, Cohen IJ, Dazard JE, Givol D, Gafter U, Motro B, Eliyahu S, Albeck M, Lander HM, Kalechman Y.
    FASEB J; 2004 Feb 30; 18(2):400-2. PubMed ID: 14656992
    [Abstract] [Full Text] [Related]

  • 11. Multifunctional activity of a small tellurium redox immunomodulator compound, AS101, on dextran sodium sulfate-induced murine colitis.
    Halpert G, Eitan T, Voronov E, Apte RN, Rath-Wolfson L, Albeck M, Kalechman Y, Sredni B.
    J Biol Chem; 2014 Jun 13; 289(24):17215-27. PubMed ID: 24764299
    [Abstract] [Full Text] [Related]

  • 12. Tellurium compound AS101 ameliorates experimental autoimmune encephalomyelitis by VLA-4 inhibition and suppression of monocyte and T cell infiltration into the CNS.
    Lee JH, Halperin-Sheinfeld M, Baatar D, Mughal MR, Tae HJ, Kim JW, Carter A, Lustig A, Snir O, Lavie G, Okun E, Mattson MP, Sredni B, Taub DD.
    Neuromolecular Med; 2014 Jun 13; 16(2):292-307. PubMed ID: 24272426
    [Abstract] [Full Text] [Related]

  • 13. Cytokine profile of patients with mycosis fungoides and the immunomodulatory effect of AS101.
    Shohat M, Hodak E, Sredni B, Shohat B, Sredni D, David M.
    Acta Derm Venereol; 2001 Jun 13; 81(4):255-7. PubMed ID: 11720171
    [Abstract] [Full Text] [Related]

  • 14. Anti-IL-10 therapeutic strategy using the immunomodulator AS101 in protecting mice from sepsis-induced death: dependence on timing of immunomodulating intervention.
    Kalechman Y, Gafter U, Gal R, Rushkin G, Yan D, Albeck M, Sredni B.
    J Immunol; 2002 Jul 01; 169(1):384-92. PubMed ID: 12077268
    [Abstract] [Full Text] [Related]

  • 15. Resolution of inflammation-related apoptotic processes by the synthetic tellurium compound, AS101 following liver injury.
    Brodsky M, Hirsh S, Albeck M, Sredni B.
    J Hepatol; 2009 Sep 01; 51(3):491-503. PubMed ID: 19595469
    [Abstract] [Full Text] [Related]

  • 16. The synthetic tellurium compound, AS101, is a novel inhibitor of IL-1beta converting enzyme.
    Brodsky M, Yosef S, Galit R, Albeck M, Longo DL, Albeck A, Sredni B.
    J Interferon Cytokine Res; 2007 Jun 01; 27(6):453-62. PubMed ID: 17572009
    [Abstract] [Full Text] [Related]

  • 17. Ammonium trichloro [1,2-ethanediolato-O,O']-tellurate cures experimental visceral leishmaniasis by redox modulation of Leishmania donovani trypanothione reductase and inhibiting host integrin linked PI3K/Akt pathway.
    Vishwakarma P, Parmar N, Chandrakar P, Sharma T, Kathuria M, Agnihotri PK, Siddiqi MI, Mitra K, Kar S.
    Cell Mol Life Sci; 2018 Feb 01; 75(3):563-588. PubMed ID: 28900667
    [Abstract] [Full Text] [Related]

  • 18. Immunomodulating tellurium compounds as anti-cancer agents.
    Sredni B.
    Semin Cancer Biol; 2012 Feb 01; 22(1):60-9. PubMed ID: 22202556
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Medicinal Hypervalent Tellurium Prodrugs Bearing Different Ligands: A Comparative Study of the Chemical Profiles of AS101 and Its Halido Replaced Analogues.
    Chiaverini L, Cirri D, Tolbatov I, Corsi F, Piano I, Marrone A, Pratesi A, Marzo T, La Mendola D.
    Int J Mol Sci; 2022 Jul 06; 23(14):. PubMed ID: 35886853
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.